NCT04187599View on ClinicalTrials.gov

Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 29, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2020

Conditions
Myopia
Interventions
DEVICE

Paragon CRT®100 Contact Lens

Paragon CRT® 100 Contact Lenses for Corneal Refractive Therapy are indicated for use in the reduction of myopic refractive error in nondiseased eyes.

Trial Locations (4)

Unknown

RECRUITING

Changsha Aier Eye Hospital, Shanghai

RECRUITING

Eye & ENT Hospital of Fudan University, Shanghai

RECRUITING

Tianjin Eye Hospital, Tianjin

RECRUITING

The Affiliated Eye Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors
collaborator

TigerMed

INDUSTRY

lead

CooperVision International Limited (CVIL)

INDUSTRY